News

Intermediate Solution by Intra-articular Injection Without Surgery

Osteoarthritis causes reduced movement and pain due to the disruption of the cartilaginous structures on the joint surface. New solutions offer treatments without surgery. One of the most important treatments recently accepted all over the world is intra-articular injection, which slows the progression of osteoarthritis.

Knee, hip, ankle, finger, and spinal joints are the sites in the body most commonly affected by osteoarthritis,

Trinova lenses cease eyeglasses need: VSY Biotechnology

Over past eight years, 3 million people have been implanted VSY Biotechnology intraocular lenses through cataract surgeries, says CEO Ozge Altunbas Goktekin

Acriva Trinova lenses not only manage cataract, but also provides continuous sight on near, mid, far and intermediate ranges, CEO of the Netherlands based company VSY Biotechnology said.

“Thus,

Acriva Trinova Trifocal

VSY Biotechnology announced the launch of its Acriva Trinova Trifocal IOL (Figure 4) at the meeting. The Acriva Trinova is manufactured with VSY’s Seamless Vision Technology, a patent-pending technique that produces an optical surface with no sharp edges. The concept provides a continuous range of vision and helps to reduce halos and scattered light, according to VSY.

VSY Biotechnology Intraocular Lenses Give Clear Vision to 3 Million People

VSY Biotechnology Chairman Ercan Varlıbaş, M.D., visits the ASCRS Annual Meeting in Washington. Each year his company exports cataract lenses worth millions of dollars, VSY Biotechnology intraocular lenses have helped 3 million of people with eye problems, around the world to achieve clear vision.

Dr. Ercan Varlıbaş, Chairman of VSY Biotechnology, recently visited the American Cataract and Refractive Surgery Association (ASCRS) Annual Meeting and Scientific Session in Washington,

In relation to misinformation Carl Zeiss Meditec AG was imposed a penalty.

About the patent litigation related to Tri-ED IOL in the District Court of Düsseldorf between Carl Zeiss Meditec AG and VSY Biotechnology BV, Carl Zeiss Meditec AG was publishing a misleading and unlawful press release from its Webservers. Because of that press release, VSY Biotechnology BV was appealing to Court and requesting to remove it.

On 2nd May 2018, District Court of Hamburg imposed a penalty on Carl Zeiss Meditec AG.

About the patent litigation related to Tri-ED IOL in the District Court of Düsseldorf between Carl Zeiss Meditec AG and VSY Biotechnology BV, Carl Zeiss Meditec AG was publishing a misleading and unlawful press release from its Webservers. Because of that press release, VSY Biotechnology BV was appealing to Court and requesting to remove it.

Near, middle, far – and everything in between

AcrivaUD Trinova: creating better visual outcomes with a sinusoidal approach to trifocality

Not all multifocal IOLs are equal. A crucial part of the conversation between a patient who wants a multifocal IOL and the surgeon is finding out the patient’s ideal near and intermediate distances are – and then the multifocal IOL that would most closely match their preferences is selected.

Revolution in Trifocal IOL

VSY Biotechnology is pleased to announce the official launch of Acriva Trinova Trifocal IOL with Seamless Vision Technology (SVT) and Unique Diffraction Pattern Derived from Sinusoidal Functions. (Patent Pending)

A new era begins!

VSY Biotechnology is proud to announce Acriva Trinova Trifocal IOL in European Cataract and Refractive Society Congress which will be held in Lisbon,

The German court has granted a preliminary injunction in favour of VSY Biotechnology BV and against Carl Zeiss Meditec

The German Court has granted a preliminary injunction in favour of VSY Biotechnology BV and against Carl Zeiss Meditec AG (Zeiss), in the action brought by VSY Biotechnology BV, against Zeiss, with allegation that it had provided misleading information to the public in its press release.

VICTORY FOR VSY BIOTECHNOLOGY

 

Stable fixation with Acriva plate haptic design

Dr. Jamil Hasanov performs scleral fixation with Acriva UDM 611.

Scleral fixation of aspheric plate-haptic lens produces good visual outcome.

Visit http://www.eurotimes.org/stable-fixation/

START TYPING AND PRESS ENTER TO SEARCH